Breast cancer, for example, is recognized as a heterogeneous disease with clinically distinct subtypes based on estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression [4]. This evidence concerns the gene ERBB2 and breast carcinoma.